Evidence map›Paper›PMID 39639094›Full record

ArticleScientific reports2024

DMSO might impact ligand binding, capsid stability, and RNA interaction in viral preparations.

Jiri Wald, Nikolaus Goessweiner-Mohr, Antonio Real-Hohn, Dieter Blaas, Thomas C Marlovits

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiri Wald *Institute of Microbial and Molecular Sciences, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. jiri.wald@cssb-hamburg.de.
Nikolaus Goessweiner-MohrInstitute of Biophysics, Johannes Kepler University (JKU), Linz, Austria.
Antonio Real-HohnCenter for Medical Biochemistry, Max Perutz Laboratories, Vienna Biocenter, Medical University of Vienna, Vienna, Austria.
Dieter Blaas *Center for Medical Biochemistry, Max Perutz Laboratories, Vienna Biocenter, Medical University of Vienna, Vienna, Austria. dieter.blaas@meduniwien.ac.at.
Thomas C MarlovitsInstitute of Microbial and Molecular Sciences, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. marlovits@marlovitslab.org.

Funding

Austrian Science Fund #27444Austrian Science Fund,Austria #31392Deutsche Forschungsgemeinschaft INST152/772-1
6 · The paper itself

Abstract

Dimethyl sulfoxide (DMSO) is a widely used solvent in drug research. However, recent studies indicate that even at low concentration DMSO might cause structural changes of proteins and RNA. The pyrazolopyrimidine antiviral OBR-5-340 dissolved in DMSO inhibits rhinovirus-B5 infection yet is inactive against RV-A89. This is consistent with our structural observation that OBR-5-340 is only visible at the pocket factor site in rhinovirus-B5 and not in RV-A89, where the hydrophobic pocket is collapsed. Here, we analyze the impact of DMSO in RV-A89 by high-resolution cryo-electron microscopy. Our 1.76 Å cryo-EM reconstruction of RV-A89 in plain buffer, without DMSO, reveals that the pocket-factor binding site is occupied by myristate and that the previously observed local heterogeneity at protein-RNA interfaces is absent. These findings suggest that DMSO elutes the pocket factor, leading to a collapse of the hydrophobic pocket of RV-A89. Consequently, the conformational heterogeneity observed at the RNA-protein interface in the presence of DMSO likely results from increased capsid flexibility due to the absence of the pocket factor and DMSO-induced affinity modifications. This local asymmetry may promote a directional release of the RNA genome during infection.

Indexed as

CapsidCryoelectron MicroscopyDimethyl SulfoxideRNA, ViralAntiviral AgentsBinding SitesCapsid ProteinsHumansLigandsProtein BindingRhinovirusAntiviral AgentsCapsid ProteinsDimethyl SulfoxideLigandsRNA, ViralDimethyl sulfoxideDMSOHRVPocket factorRhinovirus

Identifiers

PMID39639094
PMCPMC11621809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.